Stephen Parker

Stephen Parker

Net worth: 184 194 $ as of 31/08/2026

67 year
Health Technology
Finance
Commercial Services

Profile

Dr. Stephen B. Parker is a Non-Executive Chairman at Biodexa Pharmaceuticals Plc, a Non-Executive Chairman at Drishti Discoveries Ltd., an Executive Chairman at Sareum Holdings Plc and a Partner at Celtic Pharma Management LP.
He is on the Board of Directors at Eternans Ltd., Sp2 Asset Management Ltd., Sareum Ltd. and Sp2 Consulting Ltd. Dr. Parker was previously employed as a Non-Executive Chairman by MGC Pharmaceuticals Ltd., a Chairman by Liverpool Chirochem Ltd., an Independent Non-Executive Director by Silence Therapeutics Plc, a Partner by Beehive Capital LLP, a Non-Executive Chairman by Physiomics Plc, a Principal by Celtic Pharma Holdings Advisors LLP, a Chief Financial Officer by Oxford GlycoSciences Plc, a Chairman by Ah Animal Healthcare Ltd., a Principal by Apax Partners LLP, a Principal by Barings Plc, a Head-Partner Network, Research & Development by Bedford Royalties Ltd., a Non-Executive Director by Gammadelta Therapeutics Ltd., a Consultant by PA Consulting Group Holdings Ltd., a Co-Founder by UK Stem Cell Foundation, and a Principal by Warburg Group Plc.
He also served on the board at Albucasis Ltd., Celtic Pharma Development UK Plc, Celtic Pharma GP Ltd., Houlihan Lokey Advisory Ltd., Novacta Biosystems Ltd., PBB Devices Ltd., Xenova Group Plc and Xenova Ltd. He received his undergraduate degree from the University of East Anglia, an MBA from Bayes Business School and a doctorate degree from the University of Oxford.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
26/03/2025 405,045 ( 0.29% ) 184 194 $ 31/08/2026
12/03/2026 0 ( -.--% ) - $ 31/08/2026

Stephen Parker active positions

CompaniesPositionStart
BIODEXA PHARMACEUTICALS PLC Chairman 20/06/2022
SAREUM HOLDINGS PLC Chairman 17/05/2016
Sp2 Consulting Ltd.
Director/Board Member -
Eternans Ltd.
Director/Board Member 01/07/2019
Chairman 01/01/2021
Director/Board Member -
Sp2 Asset Management Ltd.
Director/Board Member 01/09/2018
Private Equity Investor 01/04/2005

Former positions of Stephen Parker

CompaniesPositionEnd
ARGENT BIOPHARMA LIMITED Chairman 01/12/2023
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Stephen Parker's experience

Training of Stephen Parker

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

33

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies33

Commercial Services

Miscellaneous

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Commercial Services

Finance

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Finance

Finance

Consumer Services

Miscellaneous

Health Technology

Finance

Health Technology

Retail Trade

Celtic Pharma GP Ltd.

Xenova Ltd.

Commercial Services

Health Technology

Health Technology

Sp2 Consulting Ltd.

Health Technology

Health Technology

Eternans Ltd.

Health Technology

Sp2 Asset Management Ltd.

  1. Stock Market
  2. Insiders
  3. Stephen Parker